Communiqués

02/11/22 Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon AQ
01/11/22 Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring AQ
25/10/22 Bionime RIGHTEST iFree CGM System - An Innovative Approach to Keep Track of Every One Health AQ
04/08/22 Bionime : Announcement of change the Globle Sales Division officer of the company. PU
05/07/22 Bionime : Announcement of members of the first order audit committee of the Company. PU
05/07/22 Bionime : Announcement of the re-election of the Chairperson of the Board of directors. PU
05/07/22 Bionime : Announcement of the members of the 5th Remuneration Committee. PU
04/07/22 Bionime : Announcement of the adjustment of cash dividends ratio PU
27/06/22 Bionime : Announcement of the ex-dividend record date PU
22/06/22 Bionime : Approved the proposal of Release the Prohibition on Directors from Participation in Competitive Business. PU
22/06/22 Bionime : Announcement of the company's 2022 annual meeting of shareholders to comprehensively re-elected directors (including independent directors) elected list. PU
14/04/22 Bionime containerized applications have proven to quickly go to the cloud and leverage AWS to solve deployment issues AQ
22/03/22 Bionime : The Board of Directors resolution of the capital reduction for treasury stocks and the record date of capital reduction PU
22/03/22 Bionime : The Company’s independent directors raised opinions to board resolutions. PU
Aucun résultat pour cette recherche